No abstract available
Keywords:
COVID-19; infectious diseases; metabolomics; personalized medicine; tuberculosis.
Grants and funding
This study was supported by the South African Technology Innovation Agency (TIA) (a subsidiary of the Department of Science and Innovation (DSI)) and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2018R1A5A2021242).